Search

Your search keyword '"Tobe, Sheldon"' showing total 58 results

Search Constraints

Start Over You searched for: Author "Tobe, Sheldon" Remove constraint Author: "Tobe, Sheldon" Database Academic Search Index Remove constraint Database: Academic Search Index
58 results on '"Tobe, Sheldon"'

Search Results

1. Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials.

3. Renal denervation for uncontrolled hypertension.

4. Diabetes prevalence and demographics in 25 First Nations communities in northwest Ontario (2014-2017).

5. Diagnosing hypertension in Indigenous Canadians (DREAM-GLOBAL): A randomized controlled trial to compare the effectiveness of short message service messaging for management of hypertension: Main results.

6. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.

7. Angiotensin Receptor-Neprilysin Inhibitor Therapy for Heart Failure With Preserved Ejection Fraction Improves Renal Outcomes.

8. Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE.

9. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 update.

10. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative.

11. The impact of endothelin-1 genetic analysis and job strain on ambulatory blood pressure

12. DreamTel; Diabetes risk evaluation and management tele-monitoring study protocol.

13. Amlodipine Added to Quinapril vs Quinapril Alone for the Treatment of Hypertension in Diabetes: The Amlodipine in Diabetes (ANDI) Trial.

14. Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial.

15. Applying the 2005 Canadian Hypertension Education Program recommendations: 5. Therapy for patients with hypertension and diabetes mellitus.

16. Microalbuminuria in diabetes mellitus.

19. Is therapy of people with chronic kidney disease ONTARGET?

20. Valve Replacement Surgery Complicated by Acute Renal Failure—Predictors of Early Mortality.

21. Association of prior outpatient diabetes screening with cardiovascular events and mortality among people with incident diabetes: a population-based cohort study.

22. Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes.

23. Ups and downs of hypertension control in Canada: critical factors and lessons learned.

25. Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes.

26. Factors associated with suboptimal initiation of dialysis despite early nephrologist referral.

27. Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk.

28. Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline.

29. Ups and downs of hypertension control in Canada: critical factors and lessons learned.

30. A retrospective observational population‐based study to assess the prevalence and burden of illness of type 2 diabetes with an estimated glomerular filtration rate < 90 mL/min/1.73 m2 in Ontario, Canada.

31. Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.

32. Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study.

33. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

34. Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial.

35. Baseline characteristics and enrichment results from the SONAR trial.

36. Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.

37. Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.

38. Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study.

39. The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.

40. The Cardiovascular Health in Ambulatory Care Research Team performance indicators for the primary prevention of cardiovascular disease: a modified Delphi panel study.

41. Comparison of exposure response relationship of atrasentan between North American and Asian populations.

42. Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program.

43. Hypertension in Russia: Changes Observed After 4 Years of a Comprehensive Health System Improvement Program in the Yaroslavl Region.

44. I-RREACH: an engagement and assessment tool for improving implementation readiness of researchers, organizations and communities in complex interventions.

45. Changes in Hypertension Treatment in the Yaroslavl Region of Russia: Improvements Observed Between 2 Cross-Sectional Surveys.

46. Conventional versus automated measurement of blood pressure in the office (CAMBO) trial.

47. C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis.

48. Physician preferences for accredited online continuing medical education.

50. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10.

Catalog

Books, media, physical & digital resources